June 19, 2025

GLP-1 Use Reduces Opioid, Pain, Fatigue Burden in Fibromyalgia

At the EULAR 2025 Congress, researchers reported that GLP-1 receptor agonists were linked to reduced opioid use, pain, and fatigue in fibromyalgia patients based on a large real-world analysis.

Conexiant

June 19, 2025

Is More Fiber the Heart’s Ally?

A long-term U.S. study found that greater adherence to a plant-based cholesterol-lowering diet was linked to lower cardiovascular, coronary heart disease, and all-cause mortality.

Conexiant

June 18, 2025

SGLT2 Inhibitor Empagliflozin Preserves Kidney Function After Heart Attack

A secondary analysis of the EMPACT-MI trial, published in Nature Cardiovascular Research, shows that the sodium-glucose cotransporter-2 (SGLT2) inhibitor empagliflozin stabilizes kidney function and reduces heart failure hospitalizations in patients who have recently experienced a heart attack.

Conexiant

June 18, 2025

Weight Loss Showdown: Pills or Scalpel?

A large analysis presented at the ASMBS Annual Meeting found bariatric surgery led to greater long-term weight loss than GLP-1 medications semaglutide and tirzepatide over three years.

Conexiant

June 17, 2025

Global Study Maps Sex Differences in Care

A global study found sex differences in risk factors, care access, and mortality for hypertension, diabetes, and HIV, using comprehensive international datasets.

Conexiant

June 13, 2025

RSV Vaccine Approved for Younger Adults

The FDA has approved Moderna’s mRESVIA vaccine for adults aged 18 to 59 who are at increased risk for RSV, expanding its indication beyond older adults.

Conexiant

June 13, 2025

Obicetrapib May Offer LDL Benefit

In a randomized trial of more than 2,500 patients at high cardiovascular risk, obicetrapib significantly reduced low-density lipoprotein cholesterol levels when added to existing lipid-lowering therapy.

Conexiant

June 13, 2025

5-Year Mortality Increases After Ocular Trauma in Geriatric Patients

Comorbidities, such as dementia, cardiovascular issues, and diabetes, also pointed to higher mortality in ocular trauma cases.

Optometric Management

June 13, 2025

Lifestyle Interventions Recommended First-Line in Diabetes

A new guideline recommends using lifestyle interventions as first-line treatment to prevent, manage, and potentially reverse type 2 diabetes and prediabetes, supported by extensive clinical evidence.

Conexiant